---

Emily Chew

Emily Chew is chair of the AREDS2 study and participates in the Actions to Control Cardiovascular Risk in Diabetes trial. She is a medical retinal specialist with extensive experience in the design and implementation of clinical trials across all phases. Her principal research interests are diabetic- and age-related eye diseases.

---

Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014